Jon Rousseau Sells 220,000 Shares of BrightSpring Health Services (NASDAQ:BTSG) Stock

BrightSpring Health Services, Inc. (NASDAQ:BTSG) insider Jon Rousseau sold 220,000 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $9,053,000.00. Following the transaction, the insider owned 1,023,880 shares of the company’s stock, valued at approximately $42,132,662. The trade was a 17.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

BrightSpring Health Services Stock Performance

Shares of BTSG traded down $0.28 during trading hours on Friday, hitting $41.49. The company’s stock had a trading volume of 2,574,425 shares, compared to its average volume of 2,775,998. The company has a market cap of $8.03 billion, a price-to-earnings ratio of 40.16, a PEG ratio of 0.55 and a beta of 2.31. The business has a 50 day simple moving average of $39.50 and a two-hundred day simple moving average of $33.91. BrightSpring Health Services, Inc. has a 52-week low of $15.48 and a 52-week high of $44.87. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.57 and a quick ratio of 1.12.

BrightSpring Health Services (NASDAQ:BTSG) last released its quarterly earnings data on Friday, February 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The company had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. During the same quarter in the previous year, the firm posted $0.11 earnings per share. The business’s revenue for the quarter was up 29.3% compared to the same quarter last year. On average, equities analysts expect that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

More BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Zacks added BTSG to its Zacks Rank #1 (Strong Buy) growth list for March 6, highlighting it as a top growth pick. Best Growth Stocks to Buy for March 6th
• Positive Sentiment: Zacks similarly featured BTSG on its March 5 list of best growth / strong-buy stocks, reinforcing buy-side attention across consecutive days. Best Growth Stocks to Buy for March 5th
• Positive Sentiment: Zacks upgraded BTSG from Hold to Strong Buy and published follow-ups pointing to momentum and rising earnings estimate revisions—signals that analysts are lifting near‑term expectations. Zacks.com upgrade
• Positive Sentiment: Zacks published a piece noting surging earnings estimate revisions for BTSG, which is commonly bullish for the stock if revisions translate into higher forward EPS and investor expectations. Surging Earnings Estimates Signal Upside
• Positive Sentiment: Broker commentary (Mizuho) and media noted strong price-appreciation forecasts and heavy trading after the analyst upgrade, which can support further upside if momentum continues. Mizuho Forecasts Strong Price Appreciation Sees Strong Trading Volume After Analyst Upgrade
• Neutral Sentiment: Zacks published comparative coverage showing how BTSG stacks up vs. medical peers this year—useful context but not an immediate catalyst. Peer Performance
• Neutral Sentiment: Reported short-interest figures in the dataset show 0 shares and 0.0 days-to-cover (likely a data artifact). That suggests no clear short-position signal from the reported data and should be treated cautiously.
• Negative Sentiment: Fundamentals remain mixed: the company’s most recent quarterly report showed strong revenue growth but a small EPS miss and the stock trades at a elevated PE, which can make it vulnerable to short-term pullbacks despite positive analyst notes.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in BTSG. Vanguard Group Inc. raised its stake in shares of BrightSpring Health Services by 30.5% during the fourth quarter. Vanguard Group Inc. now owns 12,533,656 shares of the company’s stock valued at $469,385,000 after acquiring an additional 2,928,953 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in BrightSpring Health Services by 4.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,662,236 shares of the company’s stock valued at $399,302,000 after purchasing an additional 478,436 shares during the period. Invesco Ltd. raised its position in BrightSpring Health Services by 13.4% during the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock valued at $396,791,000 after purchasing an additional 1,248,107 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in BrightSpring Health Services by 21.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock worth $229,339,000 after buying an additional 1,091,757 shares during the period. Finally, Alliancebernstein L.P. increased its stake in shares of BrightSpring Health Services by 12.1% during the second quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company’s stock valued at $128,568,000 after buying an additional 588,642 shares during the period.

Analyst Upgrades and Downgrades

BTSG has been the subject of several research analyst reports. BTIG Research reissued a “buy” rating and set a $55.00 price objective on shares of BrightSpring Health Services in a research note on Monday. TD Cowen restated a “buy” rating on shares of BrightSpring Health Services in a research report on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of BrightSpring Health Services in a research note on Monday, December 29th. William Blair initiated coverage on shares of BrightSpring Health Services in a report on Monday, December 8th. They issued an “outperform” rating on the stock. Finally, Wall Street Zen lowered shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $44.08.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.